Description
| COMPOSITION: | Each uncoated bilayered tablet contains Glimepiride 1 mg, Pioglitazone 15 mg & Metformin Hydrochloride SR 500 mg |
| FORMULATION: | TABLETS |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Glimblist PM1 Tabletcontains three drugs Glimepiride 1/2 mg, Pioglitazone 15 mg & Metformin as sustain release form 500 mg that act differently to provide better diabetic control. This triple drug combination is prescribed for type II diabetes in association with diet control & exercise. |
| SIDE EFFECTS: | The main side effects are peripheral oedema, low blood sugar, weight gain, headache, diarrhoea & nausea. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician |
Reviews
There are no reviews yet.